BLASTS MORE THAN 5 PERCENT OF BONE MARROW NUCLEATED CELLS
Clinical trials for BLASTS MORE THAN 5 PERCENT OF BONE MARROW NUCLEATED CELLS explained in plain language.
Never miss a new study
Get alerted when new BLASTS MORE THAN 5 PERCENT OF BONE MARROW NUCLEATED CELLS trials appear
Sign up with your email to follow new studies for BLASTS MORE THAN 5 PERCENT OF BONE MARROW NUCLEATED CELLS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo combo tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis early-stage study is testing a new chemotherapy combination called CPX-351 in adults with high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia that has come back or hasn't responded to standard treatments. The main goals are to find the safest dose and under…
Matched conditions: BLASTS MORE THAN 5 PERCENT OF BONE MARROW NUCLEATED CELLS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 22:11 UTC
-
New hope for patients with rare, Hard-to-Treat blood disorders
Disease control Recruiting nowThis study is testing whether the drug ruxolitinib can help control rare blood disorders where the body makes too many eosinophils, a type of white blood cell. It will involve about 10 adults whose conditions have not responded well to standard treatments like steroids. The main …
Matched conditions: BLASTS MORE THAN 5 PERCENT OF BONE MARROW NUCLEATED CELLS
Phase: PHASE2 • Sponsor: William Shomali • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC